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Abstract
Background: The association between proinflammatory cytokine gene polymorphisms and gastric diseases related
to Helicobacter pylori varies by population and geographic area.
Our objective was to determine if the IL-1B -511 T>C and -31 C>T polymorphisms and H. pylori vacA genotypes are
associated with risk of chronic gastritis and gastric ulcer in a Mexican population.
Methods: We conducted endoscopic studies in 128 patients with symptoms of dyspepsia. We took two biopsies
from the body, antrum, or ulcer edge from each patient, and classified our histopathological findings according to
the Sydney System. H. pylori infection and vacA genotyping were accomplished via PCR from total DNA of the
gastric biopsies. We confirmed the presence of anti-H. pylori serum IgG and IgM in 102 control subjects. In both
case subjects and control subjects, the IL-1B -511 T>C polymorphism was genotyped by PCR-RFLPs and the IL-1B
-31 C>T polymorphism was genotyped by pyrosequencing.
Results: Sixty-two point seven (62.7%) of the 102 control subjects were H. pylori-s e r o p o s i t i v e .A m o n gt h ec a s es u b j e c t s ,
100 were diagnosed with chronic gastritis and 28 with gastric ulcer. We found that 77% of the patients with chronic
gastritis and 85.7% of the patients with gastric ulcer were H. pylori-positive. The predominant H. pylori genotype was vacA
s1m1 (58.4%) and the most frequent subtype was vacA s1.T h e- 511 TC, (rs16944 -511 T>C) genotype and the -511C allele
were associated with chronic gastritis (OR = 3.1, 95% CI = 1.4-6.8 and OR = 3.0, 95% CI = 1.4-6.0, respectively). The subjects
carrying -31T (rs1143627 -31 C>T) were found to be at a higher risk of having chronic gastritis (OR = 2.8, 95% CI = 1.3-5.8).
The IL-1B -511C/-31T haplotype was associated with chronic gastritis (OR = 2.1, 95% CI = 1.2-3.8) but not with gastric ulcer.
Conclusions: The H. pylori vacA genotypes identified herein were similar to those reported for other regions of
Mexico. The vacA s1m1 genotype was not associated with gastric ulcer. In the southern Mexican population, the
IL-1B -511C and -31T alleles and the -511C/-31T and -511T/-31T haplotypes are associated with increased risk of
chronic gastritis and gastric ulcer.
Background
Helicobacter pylori infection is related to the inflamma-
tory response of the gastric mucosa. While most infected
individuals remain asymptomatic, persistent colonization
and chronic inflammation increase the risk of developing
atrophic gastritis, peptic ulcers, and distal gastric adeno-
carcinoma [1]. The development of chronic gastritis is
the initiating event in the process that leads to stomach
cancer. The risk of malignancy increases with severity,
chronicity, and duration of the inflammatory process
[2,3]. Clinical outcome of H. pylori infection is deter-
mined by the genetic characteristics of the host and bac-
teria as well as environmental factors [4]. While H. pylori
is considered to be a class I carcinogen, it is accepted
that some genotypes have greater virulence. The strains
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large quantities of vacuolating cytotoxin (VacA) are most
frequently found in patients with peptic ulcers and gas-
tric carcinoma [2,5,6]. It has been observed that H. pylori
vacA s1/m1 strains produce high levels of the cytotoxin,
strains s1/m2 produce moderate levels, and strains s2/m2
produce little or no toxin [7,9]. The vacA s1 subtype is
related to higher disease severity and a higher risk of
developing ulcers and stomach cancer [5,6,10].
H. pylori induce production of IL-1b in the gastric
mucosa. IL-1b modulates the expression of other proin-
flammatory cytokine genes such as TNF-a, IL-2, IL-6 and
IL-12, which increase the magnitude of inflammation [11].
The concentration of IL-1b produced by the inflamed
epithelium is influenced by two biallelic polymorphisms in
positions -511T>C (rs16944) and -31C>T (rs1143627).
These polymorphisms are in almost total genetic disequili-
brium, and -31 is a TATA-box polymorphism that signifi-
cantly affects DNA-protein interactions in vitro.
Thus, these single-nucleotide polymorphisms (SNPs) can
modulate production of IL-1b, directly affecting transcrip-
tion [12,13]. Given that IL-1b is a strong inhibitor of
gastric acid secretion and may contribute to dispersion of
H. pylori from the pylorus to the corpus of the stomach,
polymorphisms in the IL-1b gene can be considered a
key genetic factor in determining the pattern of gastritis
that develops and one risk of malignant transformation
[13,14]. The IL-1B -511T and -31C alleles are associated
with high levels of the cytokine and with severe inflamma-
tion or stomach cancer, in comparison to -511C and
-31T, which are associated with low levels of IL-1b.
This association with Hp y l o r iinfection or stomach
cancer has not been significant in all populations
[2,4,6,11,13-20].
In combination, bacterium virulence factors and IL-B
polymorphisms (cagA+/vacA+/IL-1B-511T/IL-RN*2)a r e
associated with severe histological changes in the gastric
mucosa of some populations [1,4]. However, the varia-
bility of results across populations and geographic areas
has been a source of ongoing controversy [2,13,14].
While gastritis, ulcer, and duodenitis constitute the
fourth leading cause of disease in the Mexican popula-
tion [21], the genetic basis for inter-individual variations
in inflammatory response and cytokine production, in
the context of H. pylori infection, has not been well stu-
died in the Mexican population.
Genotyping of H. pylori vacA and IL-1B polymorph-
isms could be important in the early identification of
individuals at high risk for developing severe gastric dis-
eases. The objective of this study was to evaluate the
relationship between IL-1B -511 T>C and -31 C>T poly-
morphisms and the presence of chronic gastritis and
gastric ulcer, and to analyze the relationship of H. pylori
vacA genotypes with gastric ulcer.
Methods
Population
We studied 128 patients subjected to an endoscopic
study in the Specialized Unit for Gastroenterology Endo-
scopy in the city of Chilpancingo, in the state of Guer-
rero, Mexico, from April 2007 to May 2008. All subjects
suffered from functional dyspepsia, epigastric pain, and
ulcerative syndrome. Patients who had not received
H. pylori erradication therapy, and had not been treated
with proton pump inhibitors nor with gastric pH neu-
tralizers during the two months prior to the endoscopy
were included in the study. We also studied 102 subjects
without dyspepsia symptoms, from the same population
as the cases, with no history of H. pylori infection or
gastroduodenal diseases. In both groups, we excluded
subjects under non-steroidal anti-inflammatory drug
(NSAID) treatment.
Informed consent was obtained from participants or
their parents. Participants’ eating habits, socio-demo-
graphic factors, family history of gastritis or ulcers, alco-
hol consumption, and smoking habits were recorded via
surveys. The study was approved by the Bioethics Com-
mittee of the Universidad Autónoma de Guerrero.
Endoscopy and gastric histology
For each patient, endoscopy was carried out using a
video processor and video gastroscope (Fujinon, Wayne,
NJ, USA). From each patient, we took two biopsies from
the antrum, corpus, or ulcer edge; one specimen was
immediately fixed in formalin for histological testing
and the other was placed in buffer solution (Tris
10 mM pH 8.0, EDTA 20 mM pH 8.0, SDS 0.5%) for
H. pylori diagnosis. The biopsies intended for H. pylori
detection were kept at -20°C until processing. The histo-
logical sections were stained with hematoxylin-eosin and
evaluated by a pathologist using the updated Sydney
System criteria [22]. Endoscopic observation and histo-
pathological confirmation were used to determine
patient pathology.
Serology
Blood samples (5 ml) were taken from all control sub-
jects. The serum was tested for IgG and IgM anti-H.
pylori by enzyme-linked immunosorbent assay (ELISA;
International Immuno-Diagnostics, Foster City, CA,
USA) according to the manufacturer’s instructions. The
sensitivity and specificity of this method are 96% and
97%, respectively. A subject was considered H. pylori-
positive if we detected at least one of the two antibodies.
H. pylori detection and vacA genotyping
Total DNA was extracted from the gastric biopsies of
each patient via the phenol:chloroform:isoamilic alcohol
technique, after digestion with proteinase K [23].
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polymerase chain reaction (PCR) for the 16S rRNA gene.
We used 150 ng total DNA, 2.5 mM MgCl2,0 . 2m M
dNTPs (Invitrogen, Carlsbad, CA, USA), 10 pmol of each
oligonucleotide, and 1 U Platinum®Taq DNA Polymerase
(Invitrogen, Carlsbad, CA, USA) in a final volume of
15 μL. The H. pylori-positive samples were subjected to
detection of subtypes of vacA by PCR. For PCR of the
signal region (s) and medium (m), we used 300 ng total
DNA, 1.5 mM MgCl2, 0.2 mM dNTP, 15 pmol of each
oligonucleotide, and 1 U Platinum®Taq DNA Polymerase
in a final volume of 20 μL. The amplification protocols
were previously described by Atherton et al.a n dP a r ket
al. [24,25]. In each PCR, we used DNA from strain
ATCC43504, vacA s1/m1 as positive control for H. pylori
and for vacA genotypes. The template DNA was substi-
tuted with sterile deionized water in the negative control.
All PCRs were conducted in a Mastercycler® Ep gradient
thermal cycler (Eppendorf, Hamburg, Germany).
IL-1B -511 T>C and -31 C>T genotyping
We obtained peripheral blood DNA from the control
subjects using Miller’s technique [26]. Genotyping of the
IL-1B -511 T>C SNP was done via PCR-restriction frag-
ment length polymorphism (RFLP) as previously
described [1]. Eight-microliter of PCR product were
digested with 2 U AvaI (New England Biolabs, Ipswich,
MA, USA) at 37°C for 12 h and analyzed in 2% agarose
gels. The IL-1B -31 C>T SNP was genotyped by pyrose-
quencing, following the methodology described by Pérez
et al. [27]. Of the 230 samples processed, 12% were sub-
jected to PCR-RFLP for genotype verification.
Statistical Analysis
We applied X
2 or Fisher’s exact test to compare frequen-
cies between groups, and analysis of variance (ANOVA)
or Kruskal-Wallis tests to compare means and medians,
respectively. In the control group, we evaluated the
Hardy-Weinberg Equilibrium (HWE) for IL-1B poly-
morphisms. To determine the association of IL-1B poly-
morphisms with chronic gastritis and gastric ulcer, we
evaluated binomial and polynomial logistic regression
models, and used multiplicative interaction models to
study the effect of possible interactions between H. pylori
and IL-1B genotypes and gastric ulcer. We calculated
Lewontin’sD ’ statistic for linkage disequilibrium between
loci. Two-tailed statistical tests were conducted with a
significance level of 5% using STATA 10 software.
Results
Histological diagnosis
Of the 128 patients examined, 78.1% had chronic gastri-
tis and 21.9% had gastric ulcer. The majority of cases
and controls were women. The average age was 29 years
for controls (range 17-61), 46 years for chronic gastritis
cases (range 11-80), and 56 years for gastric ulcer
patients (range 25-83). There were significant differences
among the three groups in age, years of schooling, geo-
graphic origin, family history of gastritis or ulcer, and
smoking habits (p < 0.05), table 1.
H. pylori infection and vacA genotypes
In 64/102 (62.7%) control subjects anti-H. pylori antibo-
dies were detected; 47 control subjects (46.1%) were
positive for either IgG or IgM and 17 (16.7%) were IgG
+/IgM+. Of the 128 cases, 101 (78.9%) were H. pylori-
positive, and the prevalence varied by diagnosis. One
vacA genotype was detected in 85/101 (84.2%) infected
subjects and two genotypes were detected in 15/101
(14.8%) subjects. The s1m1 genotype was detected in
59/101(58.4%) infected subjects, s1m2 was detected in
37/101 (36.6%), s2m2 in 19/101 (18.8%), and s1m1/s1m2
in 15/101 (14.8%) infected subjects. One sample did not
amplify for m subtypes. Genotypes s1m1 and s1m2 were
predominant in the two groups of cases, table 2. Most,
97/116 (83.6%), typed subtypes were vacA s1. The s1var-
iant was detected in 22/25 (88%) of the patients with
ulcer and 75/91(82.4%) of those with gastritis. Co-infec-
tion with s1m1/s1m2 genotypes was more frequent in
patients with chronic gastritis (18.2%) than in those with
gastric ulcer (4.2%).There was not significant association
between the H. pylori s1 subtype and gastric ulcer (OR
= 1.9, 95%CI = 0.29-12.8, p = 0.48) as compared to
chronic gastritis. H. pylori infection was associated with
chronic gastritis (OR = 2.3, 95%CI = 1.2-4.1, p = 0.009)
and with gastric ulcer (OR = 4.0, 95%CI = 1.3-12.5, p =
0.016) as compared to controls.
IL-1B -511 T>C and -31 C>T polymorphisms
In the control group, the -511 T>C and -31 C>T IL-1B
SNPs genotypes were in Hardy-Weinberg equilibrium
(HWE) (for SNP -511 X
2 = 0.500, p = 0.479; for SNP
-31 X
2 = 0.014, p = 0.905). The genotypic frequencies of
the IL-1B -511 T>C and -31 C>T SNPs were signifi-
cantly different between the patient and control groups
(-511 T>C,p=0 . 0 1 5 ;- 31 C>T,p=0 . 0 2 7 ) .F o rr s 1 6 9 4 4
(-511 T>C), the frequency of genotype TC was greater
in patients with gastritis (60%) and ulcer (46.4%) than in
control subjects (38.2%). Genotype CC was the most fre-
quent in patients with gastric ulcer (17.9%). The geno-
type frequency distribution for rs1143627 (-31 C>T) CT
was 57.1% among patients with gastric ulcer, 52%
among patients with chronic gastritis, and 41.2% among
controls. Genotype TT was more frequent in individuals
with gastritis. The IL-1B -31T allele was the most fre-
quent among patients with chronic gastritis and ulcer
compared to control subjects, table 3. Concordance of
results between pyrosequencing and PCR-RFLP
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librium was almost complete between IL-1B-31 and IL-
1B-511 in the case subjects (D’ = 0.97; p < 0.001).
The -511TC/-31CT g e n o t y p e sw e r em o r ef r e q u e n t
among patients with chronic gastritis (48%) and patients
with gastric ulcer (42.9%); in contrast, the -511TT/-
31CC combination was present in 29% and 32.1% of
these groups, respectively. CT/TT of IL-1B -31 C>T
SNP was associated with the presence of chronic gastri-
tis (OR = 2.8, 95% CI = 1.3-5.8, p = 0.006) but not with
the presence of gastric ulcer, table 4. Adjusting for age,
place of origin, schooling, smoking habits, family history
of gastritis or gastric ulcer, and H. pylori infection, TC/
CC of IL-1B -511 T>C SNP was significantly associated
Table 1 Socio-demographic characteristics in cases and controls
Cases
Characteristic Controls
(n = 102)
Chronic gastritis
(n = 100)
Gastric ulcer
(n = 28)
p-value
Age (mean ± sd; years) 29.8 ± 11 46.1 ± 14.6 56.3 ± 17.1 <0.001
€
Gender n(%)
Female 65 (63.7) 64 (64) 19 (67.9) 0.917
θ
Male 37 (36.3) 36 (36) 9 (32.1)
Education [mean (range); years] 12 (12-17) 12 (6-17) 6 (0-12) <0.001
†
Geographical area n(%)
Chilpancingo 44 (43.1) 30 (30) 5 (17.9) 0.021
θ
Other municipalities 58 (56.9) 70 (70) 23 (82.1)
Family history of gastritis and/or ulcer n(%) 0.001
θ
No 49 (48.0) 39 (39.0) 22 (78.6)
Yes 53 (52.0) 61 (61.0) 6 (21.4)
Smoking habit n(%)
No 39 (38.2) 65 (65) 10 (35.7) <0.001
θ
Current smoker or former smoker 63 (61.8) 35 (35) 18 (64.3)
Alcohol consumption n(%)
No 14 (13.7) 22 (22) 7 (25) 0.211
θ
Consumes or consumed 88 (86.3) 78 (78) 21 (75)
€ ANOVA test;
† Kruskal-Wallis test;
θ X
2 Test;
Ω Fisher’s exact test.
Table 2 Genotype and alleles of H. pylori vacA
frequencies in cases
Genotypes or alleles Cases p-value
Chronic gastritis
n(%)
Gastric ulcer
n(%)
Genotypes
s1m1 31 (40.2) 13 (54.1) 0.254
Ω
s1m2 16 (20.8) 6 (25.0)
s2m2 16 (20.8) 3 (12.5)
s1m1 y s1m2 14 (18.2) 1 (4.2)
Not typed * - 1 (4.2)
Total 77 (100) 24 (100)
Alleles s
s1 75 (82.4) 22 (88.0) 0.551
Ω
s2 16 (17.6) 3 (12.0)
Total 91 (100) 25 (100)
Alleles m
m1 45 (49.5) 14 (58.3) 0.187
θ
m2 46 (50.5) 10 (41.7)
Total 91 (100) 24
♪ (100)
*Signal region s1genotype
Ω Fisher’s exact test
θ X
2 Test.
♪It was not possible to amplify the m allele in one biopsy.
Table 3 Genotypic distribution and allelic frequencies of
IL-1B polymorphisms in cases and controls
Cases
511 T>C SNP Controls
n (%)
Chronic gastritis
n (%)
Gastric ulcer
n (%)
p-value
Genotype
TT 53 (52.0) 31 (31.0) 10 (35.7) 0.015
θ
TC 39 (38.2) 60 (60.0) 13 (46.4)
CC 10 (9.8) 9 (9.0) 5 (17.9)
Allele
T 0.711 0.610 0.589 0.060
θ
C 0.289 0.390 0.411
-31 C>T SNP
Genotype
CC 52 (51.0) 31 (31.0) 10 (35.7) 0.027
Ω
CT 42 (41.2) 52 (52.0) 16 (57.1)
TT 8 (7.8) 17 (17.0) 2 (7.1)
Allele
C 0.716 0.570 0.643 0.009
θ
T 0.284 0.430 0.357
θ X
2 Test
Ω Fisher’s exact test
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controls (OR = 2.9, 95% CI = 1.4-5.8, p = 0.004). Separ-
ating by diagnosis, we found association of -511TC/CC
with chronic gastritis (OR = 3.0, 95%CI = 1.4-6.3, p =
0.003). The -511C/-31T and -511T/-31T haplotypes
were significantly associated with chronic gastritis but
not with gastric ulcer, table 5.
To determine whether carriers of -511C and -31T
alleles who were infected by H. pylori vacA s1 showed
higher risk of gastritis or ulcer, the OR was calculated
for the patients exposed to H. pylori vacA s1 within
each group, as compared to those infected with H.
pylori vacA s2. We did not observe significant associa-
tion between infection with H. pylori vacA s1 with
chronic gastritis or gastric ulcer in carriers of the IL-
1B-511C and -31T alleles or their haplotypes (data not
shown).
Discussion
In patients with chronic gastritis, we only found geno-
types vacA s1m1, s1m2,a n ds2m2.H o w e v e rt h em o s t
virulent allele, vacAs1, was the most frequent in patients
with both diseases. Our results agree with those
reported by other authors and confirm that the s1m1ge-
notype is in greatest circulation in Mexico [28-30]. The
lack of significant association between vacA s1m1with
gastric ulcer, as compared to chronic gastritis, may be
explained by the presence of multiple factors giving rise
to the disease and by the small sample size in our study.
Chronic infection with H. pylori induces hypochlorhy-
dria, and this is a critical factor in the development of
gastric pathology. Thus, the genetic factors in the host
that influence acid secretion can also mediate the clini-
cal progress of H. pylori infection. IL-1b is a powerful
proinflammatory cytokine that is overexpressed in the
presence of H. pylori and plays an important role in
amplifying the inflammatoryr e s p o n s et ot h ei n f e c t i o n
[1,6,31,32]. The biallelic polymorphisms in positions -31
and -511 of IL-1B influence cytokine expression; allele T
in position -31 forms a TATA-Box that can potentiate
and induce expression of IL-1b [32,33]. It has been
reported that the IL-1B -511T/IL-1B-31C alleles are sig-
nificantly associated with the development of hypochlor-
hydria, H. pylori infection, gastritis, and stomach cancer,
however the variability of results from studies conducted
in various populations remain controversial [33-36].
Interestingly, in our study, the -511 TC/CC and -31
CT/TT IL-1B genotypes were associated with the pre-
s e n c eo fc h r o n i cg a s t r i t i sa n dt h ep r e s e n c eo fg a s t r i c
ulcer when all cases were grouped (-511 TC/CC OR
adjusted =2 . 8 ,9 5 %C I=1 . 6 - 5 . 1 ;- 31 CT/TT OR adjusted =
2.9, 95% CI = 1.6-5.3). Greater risk of chronic gastritis
and stomach cancer has also been reported in Japanese
population with the -511CC genotype and in Chinese
Table 4 Association of IL-1B polymorphisms with chronic gastritis and gastric ulcer
SNP Model Genotype Gastritis Ulcer
OR (95%CI) p-value OR (95%CI) p-value
-511 T>C Co-dominant TT 1.0* 1.0*
TC 3.1 (1.4-6.8) 0.004 2.3 (0.7-7.6) 0.175
CC 2.5 (0.7-8.4) 0.148 5.0 (0.9-29.0) 0.075
Dominant TT 1.0* 1.0*
TC/CC 3.0 (1.4-6.3) 0.003 2.6 (0.8-8.2) 0.094
-31C>T Co-dominant CC 1.0* 1.0*
CT 2.3 (1.1-5.0) 0.035 2.6 (0.8-8.8) 0.112
TT 5.6 (1.8-17.6) 0.003 1.6 (0.2-12.6) 0.667
Dominant CC 1.0* 1.0*
CT/TT 2.8 (1.3-5.8) 0.006 2.5 (0.8-7.9) 0.122
* Reference category: healthy individuals. Models adjusted by age, place of origin, education, smoking habit, family history of gastritis or gastric ulcer, and H.
pylori infection.
Table 5 Haplotypes of IL-1B SNPs and their association with gastritis and gastric ulcer
Haplotype SNP Controls Cases
-511 -31 Chronic gastritis OR (95%CI) p-value Gastric ulcer OR (95%CI) p-value
1 T C 0.706 0.543 1.0* 0.570 1.0*
2 C T 0.279 0.363 2.1 (1.2-3.8) 0.02 0.338 1.3 (0.2-7.5) 0.97
3 T T 0.005 0.067 16 (1.2-221) 0.04 0.019 ID
4 C C 0.010 0.027 3 (0.4-24.6) 0.31 0.073 ID
ID: insufficient data. * Reference category. Models adjusted by age, place of origin, education, smoking habit, family history of gastritis or gastric ulcer, and
H. pylori infection.
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population, IL-1B genotype -511CC is considered a risk
factor for stomach cancer [38]. A previous study in a
Japanese population showed that subjects with the
-31TT genotype had a significantly higher risk of H.
pylori infection (OR= 1.74, 95% CI = 1.15-5.63) than
subjects with -31CT or -31CC genotypes. A similar
result was obtained for H. pylori-seropositive Japanese-
Brazilians (OR -31TT = 1.45, 95% CI = 1.02-2.07)
[13,39]. In a Korean population, the -31T polymorphism
was found to be associated with stomach cancer [33];
and in Polish and Western Scottish populations, the
-31T allele was found to be associated with both H.
pylori infection and hypochlorhydria as well as a higher
risk of stomach cancer [32]. In a Spanish population,
García-González et al.f o u n dt h a tIL-1B -511 C/-31 T
contributed to risk of duodenal ulcer [40].
In our study, the effect of the -31CT/TT and -511TC/
CC genotypes on risk of chronic gastritis was greater
when we adjusted for factors such as age, place of ori-
gin, schooling, smoking habits, family history of gastritis
or gastric ulcer, and H. pylori infection. Therefore, the
habits and lifestyles of the studied individuals modified
the risk of developing chronic gastritis. Such findings
support the multifactorial model of gastric pathology
that includes the host, H. pylori, and the environment
[13,36,39]. Given the OR values, it is likely that the
same is true for gastric ulcer, but due to the small size
of the sample it was not possible to obtain significant
associations.
To our knowledge, this is the first study to examine
the association of -511 T>C and -31 C>T SNPs in Mex-
ican patients with chronic gastritis and gastric ulcer.
Two prior studies found that the -31CC genotype was
associated with stomach cancer as compared to the
-31TT genotype (in the northeast region of Mexico, OR
= 7.6, 95% CI = 1.73-46.9; in the southeast and central
regions of Mexico, OR = 3.19, 95% CI = 1.05-9.68)
[6,41]. These differences might be the result of genomic
diversity in the populations across different regions of
Mexico. The sub-population in the northern region of
Mexico has a greater contribution of European ancestry,
while the population of Guerrero has a particularly
dominant African ancestral contribution, with a minor
European contribution and is genetically closer to the
Zapotecs [42].
Chronic gastritis and gastric ulcer are part of the nat-
ural evolution to stomach cancer [3,4], and it is possible
that a similar phenomenono c c u r si nM e x i c oa sh a s
been observed in Asian populations, in which the distri-
bution of IL-1B genotypes differs between the northern
region, where there is a high prevalence of stomach can-
cer, and the southern region, where there is a low preva-
lence of stomach cancer [33-35,43].
The information available on IL-1B alleles associated
with diseases linked to H. pylori is controversial. While
some researchers have found that IL-1B -511TT and IL-
1B -31CC are proinflammatory [32,44], others have
found, with in vitro experiments and with stomach can-
cer patients infected with H. pylori, that the IL-1B
-511C and IL-1B -31T alleles potentiate expression of
IL-1b in the gastric mucosa [33,45,46]. The results of
our work agree with those of Takagi et al.w h of o u n d
that the IL-1B -511CC/IL-1B -31TT genotypes potenti-
ate cytokine production and ares i g n i f i c a n t l ya s s o c i a t e d
with the clinical development of H. pylori infection [47].
Conclusions
Patients with chronic gastritis and gastric ulcer were
infected predominantly with H. pylori vacA s1m1 geno-
type and the vacAs1 allelotype was the most frequent.
In chronic gastritis the s1m1 y s1m2 genotypes tend to
be associated in co-infections.
I nt h ep o p u l a t i o no fs o u t h e r nM e x i c o ,- 511C or -31T
alleles and -511C/-31T or -511T/-31T haplotypes of IL-
1B increase the risk of chronic gastritis and gastric ulcer.
The results of this study support the hypothesis that the
combined effect of lifestyle, infection with virulent genotypes
of H. pylori, and genetic factors of the host, such as IL-1B
-511C/IL-1B -31T polymorphisms, can play an important
role in development of chronic gastritis and gastric ulcer in
the Mexican population of the state of Guerrero.
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